ATS GUIDELINES Bundle

Drug-Resistant Tuberculosis

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1206585

Contents of this Issue

Navigation

Page 9 of 15

10 Treatment Table 2b. Doses of Drugs for Treatment of Adults and Children with MDR-TB STEP Drug Route of Admin- istration Adults 1 Levofloxacin PO / IV 750–1000 mg daily b Moxifloxacin PO / IV 400–(600–800 mg ) daily c 2 Bedaquiline PO 400 mg daily × 14 days then 200 mg 3×/week Linezolid PO / IV 600 mg daily 3 Clofazimine PO 100 mg daily Cycloserine/terizidone PO 250–750 mg daily d to achieve serum 20–35 mg/L in plasma e 4 Amikacin IV / IM 15 mg/kg daily Streptomycin IV / IM 15 mg/kg daily. Some clinicians prefer 25 mg/kg 3 × weekly.

Articles in this issue

view archives of ATS GUIDELINES Bundle - Drug-Resistant Tuberculosis